Immunological homeostasis of the eye

Progress in Retinal and Eye Research

Volumn 33, Issue 1, 2013, Pages 10-27

  Mochizuki, Manabu ^a   Sugita, Sunao ^a,b   Kamoi, Koju ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b RIKEN Center for Biosystems Dynamics Research   (Japan)

Author keywords

Corneal endothelial cells; Effector T cells; Experimental autoimmune uveitis; Foxp3; Human T cell leukemia virus type 1 uveitis; Ocular pigment epithelial cells; Regulatory T cells; Th 17 cells; Transforming growth factor; Uveitis; Vogt Koyanagi Harada disease

Indexed keywords

CD86 ANTIGEN; GALECTIN 1; INTERLEUKIN 22; INTERLEUKIN 9; INTERPHOTORECEPTOR RETINOID BINDING PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; NITRIC OXIDE SYNTHASE; PATTERN RECOGNITION RECEPTOR; THROMBOSPONDIN 1; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA;

AUTOIMMUNE UVEITIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; CORNEA ENDOTHELIUM; CYTOKINE RELEASE; DENDRITIC CELL; EYE INFLAMMATION; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNOREGULATION; IMMUNOTHERAPY; MACROPHAGE; NEUTROPHIL; NONHUMAN; PATHOGENESIS; PIGMENT EPITHELIUM; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; RETINA INJURY; REVIEW; T LYMPHOCYTE ACTIVATION; TH17 CELL; UVEORETINITIS; VIRUS INFECTION; VOGT KOYANAGI SYNDROME;

CD4-POSITIVE T-LYMPHOCYTES; HOMEOSTASIS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, INNATE; UVEITIS;

EID: 84873438334     PISSN: 13509462     EISSN: 18731635     Source Type: Journal    
DOI: 10.1016/j.preteyeres.2012.10.002     Document Type: Review

References (209)

1. Agarwal R.K., Caspi R.R. Rodent models of experimental autoimmune uveitis. Methods Mol. Med. 2004, 102:395-419.
2. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
3. Amadi-Obi A., Yu C.R., Liu X., Mahdi R.M., Clarke G.L., Nussenblatt R.B., Gery I., Lee Y.S., Egwuagu C.E. TH17 cells contribute to uveitis and scleritis and are expanded by IL-2 and inhibited by IL-27/STATI. Nat. Med. 2007, 13:711-718.
4. Anderson M.S., Venanzi E.S., Klein L., Chen Z., Berzins S.P., Turley S.J., von Boehmer H., Bronson R., Dierich A., Benoist C., Mathis D. Projection of an immunological self shadow within the thymus by the aire protein. Science 2002, 298:1395-1401.
5. Appleman L.J., Boussiotis V.A. T cell anergy and costimulation. Immunol. Rev. 2003, 192:161-180.
6. Asukata Y., Ota M., Meguro A., Katsuyama Y., Ishihara M., Namba K., Kitaichi N., Morimoto S., Kaburaki T., Ando Y., Takenaka S., Inoko H., Ohno S., Mizuki N. Lack of association between toll-like receptor 4 gene polymorphisms and sarcoidosis-related uveitis in Japan. Mol. Vis. 2009, 15:2673-2682.
7. Avichezer D., Grajewski R.S., Chan C.C., Mattapallil M.J., Silver P.B., Raber J.A., Liou G.I., Wiggert B., Lewis G.M., Donoso L.A., Caspi R.R. An immunologically privileged retinal antigen elicits tolerance: major role for central selection mechanisms. J. Exp. Med. 2003, 198:1665-1676.
8. Barnaba V., Sinigaglia F. Molecular mimicry and T cell-mediated autoimmune disease. J. Exp. Med. 1997, 185:1529-1531.
9. Bousso P. T-cell activation by dendritic cells in the lymph node: lessons from the movies. Nat. Rev. Immunol. 2008, 8:675-684.
10. Boxus M., Twizere J.C., Legros S., Dewulf J.F., Kettmann R., Willems L. The HTLV-1 tax interactome. Retrovirology 2008, 14(5):76.
11. Broderick C., Duncan L., Taylor N., Dick A.D. IFN-{gamma} and LPS-mediated IL-10-dependent suppression of retinal microglial activation. Invest. Ophthalmol. Vis. Sci. 2000, 41:2613-2622.
12. Broderick C., Hoek R.M., Forrester J.V., Liversidge J., Sedgwick J.D., Dick A.D. Constitutive retinal CD200 expression regulates resident microglia and activation state of inflammatory cells during experimental autoimmune uveoretinitis. Am. J. Pathol. 2002, 161:1669-1677.
13. Caspi R.R., Roberge F.G., Chan C.C., Wiggert B., Chader G.J., Rozenszajn L.A., Lando Z., Nussenblatt R.B. A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J. Immunol. 1988, 140:1490-1495.
14. Caspi R.R., Silver P.B., Chan C.C., Sun B., Agarwal R.K., Wells J., Oddo S., Fujino Y., Najafian F., Wilder R.L. Genetic susceptibility to experimental autoimmune uveoretinitis in the rat is associated with an elevated Th 1 response. J. Immunol. 1996, 157:2668-2675.
15. Caspi R.R. A look at autoimmunity and inflammation in the eye. J. Clin. Invest. 2010, 120:3073-3083.
16. Chang J.H., McCluskey P.J., Wakefield D. Toll-like receptors in ocular immunity and the immunopathogenesis of inflammatory eye disease. Br. J. Ophthalmol. 2006, 90:103-108.
17. Chaon B.C., Horai R., Chen J., Zárate-Bladés C., Villasmil R., Chan C.C., Caspi R.R. The role of interleukin-17A in a spontaneous model of autoimmune uveitis elicited by retina-specific T cells. Invest. Ophthalmol. Vis. Sci. 2012, ARVO E-Abstract 6307.
18. Chen J., Vistica B.P., Takase H., Ham D.I., Fariss R.N., Wawrousek E.F., Chan C.C., DeMartino J.A., Farber J.M., Gery I. A unique pattern of up- and down-regulation of chemokine receptor CXCR3 on inflammation-inducing Th1 cells. Eur. J. Immunol. 2004, 34:2885-2894.
19. Cox C.A., Shi G., Yin H., Vistica B.P., Wawrousek E.F., Chan C.C., Gery I. Both Th1 and Th17 are immunopathogenic but differ in other key biological activities. J. Immunol. 2008, 180:7414-7422.
20. Crane I.J., Xu H., Wallace C., Manivannan A., Mack M., Liversidge J., Marquez G., Sharp P.F., Forrester J.V. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis. J. Leukoc. Biol. 2006, 79:435-443.
21. Cui Y., Shao H., Lan C., Nian H., O'Brien R.L., Born W.K., Kaplan H.J., Sun D. Major role of gamma delta T cells in the generation of IL-17+ uveitogenic T cells. J. Immunol. 2009, 183:560-567.
22. De Kozak Y., Usui M., Faure J.P. Experimental autoimmune uveoretinitis. Ultrastructure of chorioretinal lesions induced in guinea pigs by immunization against the outer rods of the bovine retina. Arch. Ophthalmol. 1976, 36:231-248.
23. De Kozak Y., Thillaye B., Renard G., Faure J.P. Hyperacute form of experimental autoimmune uveo-retinitis in Lewis rats; electron microscopic study. Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol. 1978, 208:135-142.
24. De Kozak Y., Sakai J., Thillaye B., Faure J.P. S antigen-induced experimental autoimmune uveoretinitis in rats. Curr. Eye Res. 1981, 1:327-337.
25. Dick A.D., Ford A.L., Forrester J.V., Sedgwick J.D. Flow cytometric identification of a minority population of MHC class II positive cells in the normal rat retina distinct from CD45lowCD11b/c{thorn} CD4 low parenchymal microglia. Br. J. Ophthalmol. 1995, 79:834-840.
26. Dick A.D., Siepmann K., Dees C., Duncan L., Broderick C., Liversidge J., Forrester J.V. Fas-Fas ligand-mediated apoptosis within aqueous during idiopathic acute anterior uveitis. Invest. Ophthalmol. Vis. Sci. 1999, 40:2258-2267.
27. Dick A.D. Immune mechanisms of uveitis: insights into disease pathogenesis and treatment. Int. Ophthalmol. Clin. 2000, 40:1-18.
28. Dong H., Zhu G., Tamada K., Chen L. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 1999, 5:1365-1369.
29. D'Souza C.D., Cooper A.M., Frank A.A., Mazzaccaro R.J., Bloom B.R., Orme I.M. An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis. J. Immunol. 1997, 158:1217-1221.
30. Dua H.S., Lee R.H., Lolley R.N., Barrett J.A., Abrams M., Forrester J.V., Donoso L.A. Induction of experimental autoimmune uveitis by the retinal photoreceptor cell protein, phosducin. Curr. Eye Res. 1992, 11(Suppl.):107-111.
31. Ego T., Ariumi Y., Shimotohno K. The interaction of HTLV-1 Tax with HDAC1 negatively regulates the viral gene expression. Oncogene 2002, 21:7241-7246.
32. Egwuagu C.E., Charukamnoetkanok P., Gery I. Thymic expression of autoantigens correlates with resistance to autoimmune disease. J. Immunol. 1997, 159:3109-3112.
33. Faure J.P., de Kozak Y., Dorey C., Tuyen V.V. Activite de differentes preparations antigeniques de la retine dans l'induction de l'uveo-retinite autoimmune experimentale chez le cobaye. Arch. Ophthalmol. (Paris) 1977, 37:47-60.
34. Fang J., Fang D., Silver P.B., Wen F., Li B., Ren X., Lin Q., Caspi R.R., Su S.B. The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model. Invest. Ophthalmol. Vis. Sci. 2010, 51:3092-3099.
35. Ferguson T.A., Griffith T.S. A vision of cell death: insights into immune privilege. Immunol. Rev. 1997, 156:167-184.
36. Ferguson T.A., Griffith T.S. A vision of cell death: Fas ligand and immune privilege 10 years later. Immunol. Rev. 2006, 213:228-238.
37. Ferguson T.A., Griffith T.S. The role of Fas ligand and TNF-related apoptosis-inducing ligand (TRAIL) in the ocular immune response. Chem. Immunol. Allergy 2007, 92:140-154.
38. Forrester J.V., Huitinga I., Lumsden L., Dijkstra C.D. Marrow-derived activated macrophages are required during the effector phase of experimental autoimmune uveoretinitis in rats. Curr. Eye Res. 1998, 17:426-437.
39. Forrester J.V., Xu H., Lambe T., Cornall R. Immune privilege or privileged immunity?. Mucosal Immunol. 2008, 1:372-381.
40. Forrester J.V. Privilege revisited: an evaluation of the eye's defence mechanisms. Eye 2009, 23:756-766.
41. Fujimoto C., Yu C.R., Shi G., Vistica B.P., Wawrousek E.F., Klinman D.M., Chan C.C., Egwuagu C.E., Gery I. Pertussis toxin is superior to TLR ligands in enhancing pathogenic autoimmunity, targeted at a neo-self antigen, by triggering robust expansion of Th1 cells and their cytokine production. J. Immunol. 2006, 177:6896-6903.
42. Fujimoto C., Shi G., Gery I. Microbial products trigger autoimmune ocular inflammation. Ophthalmic Res. 2008, 40:193-199.
43. Futagami Y., Sugita S., Vega J., Ishida K., Takase H., Maruyama K., Aburatani H., Mochizuki M. Role of thrombospondin-1 in T cell response to ocular pigment epithelial cells. J. Immunol. 2007, 178:6994-7005.
44. Gery I., Wiggert B., Redmond T.M., Kuwabara T., Crawford M.A., Vistica B.P., Chader G.J. Uveoretinitis and pinealitis induced by immunization with interphotoreceptor retinoid-binding protein. Invest. Ophthalmol. Vis. Sci. 1990, 27:1296-1300.
45. Gery I., Chanaud N.P., Anglade E. Recoverin is highly uveitogenic in Lewis rats. Invest. Ophthalmol. Vis. Sci. 1994, 35:3342-3345.
46. Gessain A., Barin F., Vernant J.C., Gout O., Maurs L., Calender A., de Thé G. Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis. Lancet II 1985, 40:407-410.
47. Gregerson D.S., Abrahams I.W. Immunologic and biochemical properties of several retinal proteins bound by antibodies in sera from animals with experimental autoimmune uveitis and uveitis patients. J. Immunol. 1983, 131:259-264.
48. Gregerson D.S., Sam T.N., McPherson S.W. The antigen-presenting activity of fresh, adult parenchymal microglia and perivascular cells from retina. J. Immunol. 2004, 172:6587-6597.
49. Gregerson D.S., Heuss N.D., Lehmann U., McPherson S.W. Peripheral induction of tolerance by retinal antigen expression. J. Immunol. 2009, 183:814-822.
50. Gregory M.S., Repp A.C., Holhbaum A.M., Saff R.R., Marshak-Rothstein A., Ksander B.R. Membrane Fas ligand activates innate immunity and terminates ocular immune privilege. J. Immunol. 2002, 169:2727-2735.
51. Gregory M.S., Koh S., Huang E., Saff R.R., Marshak-Rothstein A., Mukai S., Ksander B.R. A novel treatment for ocular tumors using membrane FasL vesicles to activate innate immunity and terminate immune privilege. Invest. Ophthalmol. Vis. Sci. 2005, 46:2495-2502.
52. Grajewski R.S., Silver P.B., Agarwal R.K., Su S.B., Chan C.C., Liou G.I., Caspi R.R. Endogenous IRBP can be dispensable for generation of natural CD4+CD25+ regulatory T cells that protect from IRBP-induced retinal autoimmunity. J. Exp. Med. 2006, 203:851-856.
53. Griffith T.S., Brunner T., Fletcher S.M., Green D.R., Ferguson T.A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995, 270:1158-1159.
54. Ham D.I., Kim S.J., Chen J., Vistica B.P., Fariss R.N., Lee R.S., Wawrousek E.F., Takase H., Yu C.R., Egwuagu C.E., Chan C.C., Gery I. Central immunotolerance in transgenic mice expressing a foreign antigen under control of the rhodopsin promoter. Invest. Ophthalmol. Vis. Sci. 2004, 45:857-862.
55. Harada E. Beitrag zur klinishen Kenntniss von nichteitriger Choroiditis (Choroiditis diffusa acuta). Nippon Ganka Gakkai Zasshi 1926, 30:356-378. (in Japanese).
56. Hayashi D., Kubota R., Takenouchi N., Tanaka Y., Hirano R., Takashima H., Osame M., Izumo S., Arimura K. Reduced Foxp3 expression with increased cytomegalovirus-specific CTL in HTL V-I-associated myelopathy. J. Neuroimmunol. 2008, 200:115-124.
57. Hinuma Y., Nagata K., Hanaoka M., Nakai M., Matsumoto T., Kinoshita K., Shirakawa S., Miyoshi I. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:6476-6480.
58. Hori J., Wang M., Miyashita M. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts. J. Immunol. 2006, 177:5928-5935.
59. Hori J., Taniguchi H., Wang M., Oshima M., Azuma M. GITR ligand-mediated local expansion of regulatory T cells and immune privilege of corneal allografts. Invest. Ophthalmol. Vis. Sci. 2010, 51:6556-6565.
60. Horie S., Sugita S., Futagami Y., Kawazoe Y., Kamoi K., Shirato S., Mochizuki M. Human iris pigment epithelium suppresses activation of bystander T cells via TGF-TGF receptor interaction. Exp. Eye Res. 2009, 88:1033-1042.
61. Horie S., Sugita S., Futagami Y., Yamada Y., Mochizuki M. Human retinal pigment epithelium-induced CD4+CD25+ regulatory T cells suppress activation of intraocular effector T cells. Clin. Immunol. 2010, 136:83-95.
62. Inomata H. Vogt-Koyanagi-Harada disease. Clinical Pathology of Retinochroidal Diseases 1989, 88-93. Igakushoin, Tokyo, (in Japanese). H. Inomata, K. Ohnishi, T. Mukuno, T. Ishibashi (Eds.).
63. Ishida K., Panjwani N., Cao Z., Streilein J.W. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 3. Epithelia cultured from iris, ciliary body, and retina suppress T cell activation by partially non-overlapping mechanisms. Ocul. Immunol. Inflamm. 2003, 11:91-105.
64. Ito R., Ota M., Meguro A., Katsuyama Y., Uemoto R., Nomura E., Nishide T., Kitaichi N., Horie Y., Namba K., Ohno S., Inoko H., Mizuki N. Investigation of association between TLR9 gene polymorphisms and VKH in Japanese patients. Ocul. Immunol. Inflamm. 2011, 19:202-205.
65. Iwase K., Fujii Y., Nakashima I., Kato N., Fujino Y., Kawashima H., Mochizuki M. A new method for induction of experimental autoimmune uveoretinitis (EAU) in mice. Curr. Eye Res. 1990, 9:207-216.
66. Jacobson S., Shida H., McFarlin D.E., Fauci A.S., Koenig S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature 1990, 348:245-248.
67. Janeway C.A., Medzhitov R. Innate immune recognition. Annu. Rev. Immunol. 2002, 20:197-216.
68. Jiang H.R., Lumsden L., Forrester J.V. Macrophages and dendritic cells in IRBP-induced experimental autoimmune uveoretinitis in B10RIII mice. Invest. Ophthalmol. Vis. Sci. 1999, 40:3177-3185.
69. Jiang H.R., Muckersie E., Robertson M., Forrester J.V. Antigen-specific inhibition of experimental autoimmune uveoretinitis by bone marrow-derived immature dendritic cells. Invest. Ophthalmol. Vis. Sci. 2003, 44:1598-1607.
70. Jiang G., Ke Y., Sun D., Han G., Kaplan H.J., Shao H. Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice. Invest. Ophthalmol. Vis. Sci. 2008, 49:282-289.
71. Jiang G., Ke Y., Sun D., Wang Y., Kaplan H.J., Shao H. Regulatory role of TLR ligands on the activation of autoreactive T cells by retinal astrocytes. Invest. Ophthalmol. Vis. Sci. 2009, 50:4769-4776.
72. Jiang G., Sun D., Kaplan H.J., Shao H. Retinal astrocytes pretreated with NOD2 and TLR2 ligands activate uveitogenic T cells. PLoS One 2012, 7:e40510.
73. Jiang L.Q., Streilein J.W. Immune privilege extended to allogeneic tumor cells in the vitreous cavity. Invest. Ophthalmol. Vis. Sci. 1991, 32:224-228.
74. Kamoi K., Yamamoto K., Misawa A., Miyake A., Ishida T., Tanaka Y., Mochizuki M., Watanabe T. SUV39H1 interacts with HTLV-1 Tax and abrogates Tax transactivation of HTLV-1 LTR. Retrovirology 2006, 13(3):5.
75. Kamoi K., Reid D.M., Yeoh J.S., Forrester J.V. Regulatory T cell expansion in eye draining lymph nodes plays a role in suppressing inflammation in spontaneous EAU and offers a strategy for cell-based therapy. Invest. Ophthalmol. Vis. Sci. 2011, ARVO E-Abstract 2275.
76. Kamoi K., Martin-Granados C., Bobu C., Wikstrom M.E., Degli-Esposti M.A., Steinman R.M., Forrester J.V. Anti-DEC205 mediated delivery of self-antigen to dendritic cell restores tolerance in spontaneous EAU. Invest. Ophthalmol. Vis. Sci. 2012, ARVO E-Abstract 6233.
77. Kamoi K., Mochizuki M. HTLV-1 uveitis. Front. Microbiol. 2012, 3:270.
78. Kamoi K., Mochizuki M. HTLV-1 infection and the eye. Curr. Opin. Ophthalmol. 2012, 23:557-561.
79. Kannagi M., Harada S., Maruyama I., Inoko H., Igarashi H., Kuwashima G., Sato S., Morita M., Kidokoro M., Sugimoto M., Funahashi S., Osame M., Shida H. Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells. Int. Immunol. 1991, 3:761-767.
80. Kaplan H.J. Immune response to immunization via the anterior chamber of the eye. J. Immunol. 1977, 118:809-814.
81. Kaplan H.J., Streilein J.W. Immune response to immunization via the anterior chamber of the eye. II. An analysis of F1 lymphocyte induced immune deviation. J. Immunol. 1978, 120:689-693.
82. Kawai T., Akira S. Pathogen recognition with Toll-like receptors. Curr. Opin. Immunol. 2005, 17:338-344.
83. Kawai T., Akira S. TLR signaling. Semin. Immunol. 2007, 19:24-32.
84. Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010, 11:373-384.
85. Kawashima H., Prasad S.A., Gregerson D.S. Corneal endothelial cells inhibit T cell proliferation by blocking IL-2 production. J. Immunol. 1994, 153:1982-1989.
86. Kawazoe Y., Sugita S., Keino H., Yamada Y., Imai A., Horie S., Yamagami S., Mochizuki M. Retinoic acid from retinal pigment epithelium induces T regulatory cells. Exp. Eye Res. 2012, 94:32-40.
87. Ke Y., Sun D., Jiang G., Kaplan H.J., Shao H. IL-22-induced regulatory CD11b+ APCs suppress experimental autoimmune uveitis. J. Immunol. 2011, 187(2):130-139.
88. Kerr E.C., Copland D.A., Dick A.D., Nicholson L.B. The dynamics of leukocyte infiltration in experimental autoimmune uveoretinitis. Prog. Retin. Eye Res. 2008, 27:527-535.
89. Klaska I.P., Martin-Granados C., Muckersie E., Forrester J.V. LPS-activated tolerogenic dendritic cells which suppress experimental autoimmune uveoretinitis fail to signal via TBK1/IRF3. Invest. Ophthalmol. Vis. Sci. 2012, ARVO E-Abstract 3221.
90. Koyanagi Y. Poliosis and alopecia associated with uveitis. Nippon Ganka Gakkai Zasshi 1914, 18:1183-1193. (in Japanese).
91. Kuffová L., Netuková M., Duncan L., Porter A., Stockinger B., Forrester J.V. Cross presentation of antigen on MHC class II via the draining lymph node after corneal transplantation in mice. J. Immunol. 2008, 180:1353-1361.
92. Lambe T., Leung J.C., Ferry H., Bouriez-Jones T., Makinen K., Crockford T.L., Jiang H.R., Nickerson J.M., Peltonen L., Forrester J.V., Cornall R.J. Limited peripheral T cell anergy predisposes to retinal autoimmunity. J. Immunol. 2007, 178:4276-4283.
93. Luger D., Silver P.B., Tang J., Cua D., Chen Z., Iwakura Y., Bowman E.P., Sgambellone N.M., Chan C.C., Caspi R.R. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 2008, 205:799-810.
94. Martín A.P., de Moraes L.V., Tadokoro C.E., Commodaro A.G., Urrets-Zavalia E., Rabinovich G.A., Urrets-Zavalia J., Rizzo L.V., Serra H.M. Administration of a peptide inhibitor of alpha4-integrin inhibits the development of experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 2005, 46:2056-2063.
95. Masuoka K., Sagawa K., Mochizuki M., Oisumi K., Itoh K. Polyclonal use of T-cell receptor α for human T-cell lymphotropic virus type 1-infected T cells. Invest. Ophthalmol. Vis. Sci. 1995, 36:254-258.
96. McGuire K.L., Curtiss V.E., Larson E.L., Haseltine W.A. Influence of human T-cell leukemia virus type I tax and rex on interleukin-2 gene expression. J. Virol. 1993, 67:1590-1599.
97. McMenamin P.G., Forrester J.V., Steptoe R., Dua H.S. Ultrastructural pathology of experimental autoimmune uveitis in the rat. Autoimmunity 1993, 6:83-93.
98. Michaelsson J., Barbosa H.M., Jordan K.A., Chapman J.M., Brunialti M.K., Neto W.K., Nukui Y., Sabino E.C., Chieia M.A., Oliveira A.S.B., Nixon D.F., Kallas E.G. The frequency of CD127low expressing CD4+CD25 high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis. BMC Immunol. 2008, 9:41.
99. Miura-Takeda S., Tashiro-Yamaji J., Oku H., Takahashi T., Shimizu T., Sugiyama T., Ikeda T., Kubota T., Yoshida R. Experimental autoimmune uveoretinitis initiated by non-phagocytic destruction of inner segments of photoreceptor cells by Mac-1(+) mononuclear cells. Microbiol. Immunol. 2008, 52:601-610.
100. Mochizuki M., Kuwabara T., Chan C.C., Nussenblatt R.B., Metcalfe D.D., Gery I. An association between susceptibility to experimental autoimmune uveitis and choroidal mast cell numbers. J. Immunol. 1984, 133:1699-1701.
101. Mochizuki M., Kuwabara T., McAllister C., Nussenblatt R.B., Gery I. Adoptive transfer of experimental autoimmune uveoretinitis in rats: immunopathogenic mechanisms and histological features. Invest. Ophthalmol. Vis. Sci. 1985, 26:1-9.
102. Mochizuki M., Nussenblatt R.B., Kuwabara T., Gery I. Effects of cyclosporine and other immunosuppressive drugs on experimental autoimmune uveoretinitis in rats. Invest. Ophthalmol. Vis. Sci. 1985, 26:226-232.
103. Mochizuki M., Watanabe T., Yamaguchi K., Yoshimura K., Nakashima S., Shirao M., Araki S., Takatsuki K., Mori S., Miyata N. Uveitis associated with human T-cell lymphotropic virus type I. Am. J. Ophthalmol. 1992, 114:123-129.
104. Mochizuki M., Watanabe T., Yamaguchi K., Tajima K., Yoshimura K., Nakashima S., Shirao M., Araki S., Miyata N., Mori S., Takatsuki K. Uveitis associated with human T lymphotropic virus type 1: seroepidemiological, clinical and virological studies. J. Infect. Dis. 1992, 166:943-944.
105. Mochizuki M., deSmet M. Use of immunosuppressive agents in ocular diseases. Prog. Retin. Eye Res. 1994, 13:479-506.
106. Mochizuki M., Watanabe T., Yamaguchi K., Tajima K. Human T-lymphotropic virus type I associated disease. Infection & Immunology 1996, 1366-1387. Mosby, St. Louis. J.S. Pepose, G.A. Holland, K.R. Whihelmus (Eds.).
107. Mochizuki M. Intraocular inflammation and homeostasis of the eye. Nippon Ganka Gakkai Zasshi 2009, 113:344-378. (in Japanese).
108. Nian H., Shao H., Zhang G., Born W.K., O'Brien R.L., Kaplan H.J., Sun D. Regulatory effect of T cells on IL-17+ uveitogenic T cells. Invest. Ophthalmol. Vis. Sci. 2010, 51:4661-4667.
109. Nian H., Shao H., O'Brien R.L., Born W.K., Kaplan H.J., Sun D. Activated γδ T cells promote the activation of uveitogenic T cells and exacerbate EAU development. Invest. Ophthalmol. Vis. Sci. 2011, 52:5920-5927.
110. Niederkorn J.Y., Streilein J.W. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed type hypersensitivity but normal cytotoxic T lymphocyte responses. J. Immunol. 1983, 131:2670-2674.
111. Nussenblatt R.B., Kuwabara T., de Monasterio F.M., Wacker W.B. S-antigen uveitis in primates. A new model for human disease. Arch. Ophthalmol. 1981, 99:1090-1092.
112. Nussenblatt R.B., Rodgigues M., Wacker W.B., Cevario S.J., Salinas-Carmona M.C., Gery I. Cyclosporin A. Inhibition of experimental autoimmune uveitis in Lewis rats. J. Clin. Invest. 1981, 67:1228-1231.
113. Odyniec A., Szczepanik M., Mycko M.P., Stasiolek M., Raine C.S., Selmaj K.W. Gammadelta T cells enhance the expression of experimental autoimmune encephalomyelitis by promoting antigen presentation and IL-12 production. J. Immunol. 2004, 173:682-694.
114. Oh U., Grant C., Griffith C., Fugo K., Takenouchi N., Jacobson S. Reduced Foxp3 protein expression is associated with inflammatory disease during human T lymphotropic virus type 1 Infection. J. Infect. Dis. 2006, 193:1557-1566.
115. Ohsugi T., Kumasaka T. T. Low CD4/CD8 T-cell ratio associated with inflammatory arthropathy in human T-cell leukemia virus type I Tax transgenic mice. PLoS One 2011, 6:e18518.
116. Oldstone M.B. Molecular mimicry and immune-mediated diseases. FASEB J. 1998, 12:1255-1265.
117. Ono A., Mochizuki M., Yamaguchi K., Miyata N., Watanabe T. Increased number of circulating HTLV-I infected cells in peripheral blood mononuclear cells of HTLV-I uveitis patients: a quantitative polymerase chain reaction study. Br. J. Ophthalmol. 1995, 79:270-276.
118. Ono A., Mochizuki M., Yamaguchi K., Miyata N., Watanabe T. Immunologic and virologic characterization of the primary infiltrating cells in the aqueous humor of human T-cell leukemia virus type 1 uveitis. Invest. Ophthalmol. Vis. Sci. 1997, 38:676-689.
119. Ono A., Ikeda E., Mochizuki M., Matsuoka M., Yamaguchi K., Sawada T., Yamane S., Tokudome S., Watanabe T. Provirus load in patients with human T-cell leukemia virus type 1 uveitis correlates with precedent Graves' disease and disease activity. Jpn. J. Cancer Res. 1998, 89:608-614.
120. Penfold P.L., Madigan M.C., Provis J.M. Antibodies to human leukocyte antigens indicate subpopulations of microglia in human retina. Vis. Neurosci. 1991, 7:383-388.
121. Percopo C.M., Hooks J.J., Shinohara T., Caspi R., Detrick B. Cytokine-mediated activation of a neuronal retinal resident cell provokes antigen presentation. J. Immunol. 1990, 145:4101-4107.
122. Pouvreau I., Zech J.C., Thillaye-Goldenberg B., Naud M.C., Van Rooijen N., de Kozak Y. Effect of macrophage depletion by liposomes containing dichloromethylene-diphosphonate on endotoxin-induced uveitis. J. Neuroimmunol. 1998, 86:171-181.
123. Pulendran B. Variegation of the immune response with dendritic cells and pathogen recognition receptors. J. Immunol. 2005, 174:2457-2465.
124. Ramirez J.M., Brembilla N.C., Sorg O., Chicheportiche R., Matthes T., Dayer J.M., Saurat J.H., Roosnek E., Chizzolini C. Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur. J. Immunol. 2010, 40:2450-2459.
125. Raveney B.J., Copland D.A., Dick A.D., Nicholson L.B. TNFR1-dependent regulation of myeloid cell function in experimental autoimmune uveoretinitis. J. Immunol. 2009, 183:2321-2329.
126. Raveney B.J., Copland D.A., Calder C.J., Dick A.D., Nicholson L.B. TNFR1 signalling is a critical checkpoint for developing macrophages that control of T- cell proliferation. Immunology 2010, 131:340-349.
127. Rajan A.J., Asensio V.C., Campbell I.L., Brosnan C.F. Experimental autoimmune encephalomyelitis on the SJL mouse: effect of T cell depletion on chemokine and chemokine receptor expression in the central nervous system. J. Immunol. 2000, 164:2120-2130.
128. Richardson J.H., Edwards A.J., Cruickshank J.K., Rudge P., Dalgleish A.G. In vivo cellular tropism of human T-cell leukemia virus type 1. J. Virol. 1990, 64:5682-5687.
129. Robek M.D., Ratner L. Immortalization of CD4+ and CD8+ T lymphocytes by human T-cell leukemia virus type 1 Tax mutants expressed in a functional molecular clone. J. Virol. 1999, 73:4856-4865.
130. Rubartelli A., Lotze M.T. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol. 2007, 28:429-436.
131. Sagawa K., Mochizuki M., Masuoka K., Katagiri K., Katayama T., Maeda T., Tanimoto A., Sugita S., Watanabe T., Itoh K. Immunopathological mechanisms of human T cell lymphotropic virus type 1 (HTLV-I) uveitis: detection of HTLV-I-infected T cells in the eye and their constitutive cytokine production. J. Clin. Invest. 1995, 95:852-858.
132. Salinas-Carmona M.C., Nussenblatt R.B., Gery I. Experimental autoimmune uveitis in the athymic nude rat. Eur. J. Immunol. 1982, 12:481-484.
133. Satou Y., Yasunaga J., Zhao T., Yoshida M., Miyazato P., Takai K., Shimizu K., Ohshima K., Green P.L., Ohkura N., Tomoyuki Yamaguchi T., Ono M., Sakaguchi S., Matsuoka M. HTLV-1 bZIP factor induces T-cell lymphoma and systemic inflammation in vivo. PLoS Pathog. 2011, 7:e1001274.
134. Sakaguchi S., Sakaguchi N. Regulatory T cells in immunologic self-tolerance and autoimmune disease. Int. Rev. Immunol. 2005, 24:211-226.
135. Schwartz R.H. T cell anergy. Annu. Rev. Immunol. 2003, 21:305-334.
136. Shi G., Cox C.A., Vistica B.P., Tan C., Wawrousek E.F., Gery I. Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells. J. Immunol. 2008, 181:7205-7213.
137. Shinohara T., Singh V.K., Tsuda M., Yamaki K., Abe T., Suzuki S. S-antigen: from gene to autoimmune uveitis. Exp. Eye Res. 1990, 50:751-757.
138. Singh V.K., Yamaki K., Abe T., Shinohara T. Molecular mimicry between uveitopathogenic site of retinal S-antigen and Escherichia coli protein: induction of experimental autoimmune uveitis and lymphocyte cross-reaction. Cell. Immunol. 1989, 122:262-273.
139. Singh V.K., Yamaki K., Donoso L.A., Shinohara T. Molecular mimicry. Yeast histone H3-induced experimental autoimmune uveitis. J. Immunol. 1989, 142:1512-1517.
140. Singh V.K., Kalra H.K., Yamaki K., Abe T., Donoso L.A., Shinohara T. Molecular mimicry between a uveitopathogenic site of S-antigen and viral peptides. Induction of experimental autoimmune uveitis in Lewis rats. J. Immunol. 1990, 144:1282-1287.
141. Singh V.K., Usukura J., Shinohara T. Molecular mimicry: uveitis induced in Macaca fascicularis by microbial protein having sequence homology with retinal S-antigen. Jpn. J. Ophthalmol. 1992, 36:108-116.
142. Sonoda K.H., Sasa Y., Qiao H., Tsutsumi C., Hisatomi T., Komiyama S., Kubota T., Sakamoto T., Kawano Y., Ishibashi T. Immunoregulatory role of ocular macrophages: the macrophages produce RANTES to suppress experimental autoimmune uveitis. J. Immunol. 2003, 171:2652-2659.
143. Spahn T.W., Issazadah S., Salvin A.J., Weiner H.L. Decreased severity of myelin oligodendrocyte glycoprotein peptide 33-35-induced experimental autoimmune encephalomyelitis in mice with a disrupted TCR chain gene. Eur. J. Immunol. 1999, 29:4060-4071.
144. Steinman R.M. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mt Sinai J. Med. 2001, 68:160-166.
145. Streilein J.W., Niederkorn J.Y., Shadduck J.A. Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens. J. Exp. Med. 1980, 152:1121-1125.
146. Streilein J.W. Immune regulation and the eye: a dangerous compromise. FASEB J. 1987, 1:199-208.
147. Streilein J.W., Masli S., Takeuchi M., Kezuka T. The eye's view of antigen presentation. Human Immunol. 2002, 63:435-443.
148. Streilein J.W. Ocular immune privilege therapeutic opportunities from an experiment of nature. Nat. Rev. Immunol. 2003, 3:879-889.
149. Su S.B., Silver P.B., Grajewski R.S., Agarwal R.K., Tang J., Chan C.C., Caspi R.R. Essential role of the MyD88 pathway, but non-essential roles of TLRs 2, 4, and 9, in the adjuvant effect promoting Th1-mediated autoimmunity. J. Immunol. 2005, 175:6303-6310.
150. Sugita S., Sagawa K., Mochizuki M., Shichijo S., Itoh K. Melanocyte lysis by cytotoxic T lymphocytes recognizing the MART-1 melanoma antigen in HLA-A2 patients with Vogt-Koyanagi-Harada disease. Int. Immunol. 1996, 8:799-803.
151. Sugita S., Streilein J.W. Iris pigment epithelium expressing CD86 (B7-2) directly suppresses T cell activation in vitro via binding to cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med. 2003, 198:161-171.
152. Sugita S., Ng T.F., Schwartzkopff J., Streilein J.W. CTLA-4+CD8+ T cells that encounter B7-2+ iris pigment epithelial cells express their own B7-2 to achieve global suppression of T cell activation. J. Immunol. 2004, 172:4184-4194.
153. Sugita S., Futagami S., Smith B., Naggar H., Mochizuki M. Retinal and ciliary body pigment epithelium suppress activation of T lymphocytes via transforming growth factor beta. Exp. Eye Res. 2006, 83:1459-1471.
154. Sugita S., Ng T.F., Lucas P.J., Gress R.E., Streilein J.W. B7+ iris pigment epithelium induced CD8+ T regulatory cells; both suppress CTLA-4+ T cells. J. Immunol. 2006, 176:118-127.
155. Sugita S., Keino H., Futagami Y., Takase H., Mochizuki M., Stein-Streilein J., Streilein J.W. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells. Invest. Ophthalmol. Vis. Sci. 2006, 47:5376-5384.
156. Sugita S., Takase H., Taguchi C., Imai Y., Kamoi K., Kawaguchi T., Sutamoto Y., Futagami Y., Itoh K., Mochizuki M. Ocular infiltrating CD4+ cells from patients with Vogt-Koyanagi-Harada disease recognize human melanocyte antigens. Invest. Ophthalmol. Vis. Sci. 2006, 47:2547-2554.
157. Sugita S., Futagami Y., Horie S., Mochizuki M. Transforming growth factor β-producing Foxp3+CD8+CD25+ T cells induced by iris pigment epithelial cells display regulatory phenotype and acquire regulatory functions. Exp. Eye Res. 2007, 85:626-636.
158. Sugita S., Horie S., Nakamura O., Futagami Y., Takase H., Keino H., Aburatani H., Katunuma N., Ishidoh K., Yamamoto Y., Mochizuki M. Retinal pigment epithelium-derived CTLA-2 induces TGF-producing regulatory cells. J. Immunol. 2008, 181:7525-7536.
159. Sugita S., Horie S., Nakamura O., Maruyama K., Takase H., Usui Y., Takeuchi M., Ishidoh K., Koike M., Uchiyama Y., Peters C., Yamamoto Y., Mochizuki M. Acquisition of T regulatory function in cathepsin L-inhibited T cells by eye-derived CTLA-2 during inflammatory conditions. J. Immunol. 2009, 183:5013-5022.
160. Sugita S., Usui Y., Horie S., Futagami Y., Aburatani H., Okazaki T., Honjo T., Takeuchi M., Mochizuki M. T-cell suppression by programmed cell death 1 ligand 1 on retinal pigment epithelium during inflammatory conditions. Invest. Ophthalmol. Vis. Sci. 2009, 50:2862-2870.
161. Sugita S., Usui Y., Horie S., Futagami Y., Yamada Y., Ma J., Kezuka T., Hamada H., Usui T., Mochisuki M., Yamagami S. Human corneal endothelial cells expressing programmed death-ligand 1 (PD-L1) suppress PD-1+ T helper 1 cells by a contact-dependent mechanism. Invest. Ophthalmol. Vis. Sci. 2009, 50:263-272.
162. Sugita S. Role of ocular pigment epithelial cells in immune privilege. Arch. Immunol. Ther. Exp. 2009, 57:263-268.
163. Sugita S., Horie S., Yamada Y., Keino H., Usui Y., Takeuchi M., Mochizuki M. Suppression of bystander T helper 1 cells by iris pigment epithelium-induced regulatory T cells via negative costimulatory signals. Invest. Ophthalmol. Vis. Sci. 2010, 51:2529-2536.
164. Sugita S., Horie S., Yamada Y., Mochizuki Inhibition of B-cell activation by retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 2010, 51:5783-7588.
165. Sugita S., Yamada Y., Horie S., Nakamura O., Ishidoh K., Yamamoto Y., Yamagami S., Mochizuki M. Induction of T regulatory cells by cytotoxic T-lymphocyte antigen-2 on corneal endothelial cells. Invest. Ophthalmol. Vis. Sci. 2011, 52:2598-2605.
166. Sugita S., Horie S., Yamada Y., Kawazoe Y., Takase H., Mochizuki M. Suppression of interleukin-17-producing T-helper 17 cells by retinal pigment epithelial cells. Jpn. J. Ophthalmol. 2011, 55:565-575.
167. Sugita S., Kawazoe Y., Yamada Y., Imai A., Horie S., Yamagami S., Mochizuki M. Inhibitory effect of corneal endothelial cells on IL-17-producing Th17 cells. Br. J. Ophthalmol. 2012, 96:293-299.
168. Tagawa T., Nishimura H., Yajima T., Hara H., Kishihara K., Matsuzaki G., Yoshino I., Maehara Y., Yoshikai Y. Vdelta1+ gammadelta T cells producing CC chemokines may bridge a gap between neutrophils and macrophages in innate immunity during Escherichia coli infection in mice. J. Immunol. 2004, 173:5156-5164.
169. Takahashi T., Takase H., Urano T., Sugita S., Miyata K., Miyata N., Mochizuki M. Clinical features of human T-lymphotropic virus type 1 uveitis: a long-term follow-up. Ocul. Immunol. Inflamm. 2000, 8:235-241.
170. Takase H., Yu C.R., Mahdi R.M., Douek D.C., Dirusso G.B., Midgley F.M., Dogra R., Allende G., Rosenkranz E., Pugliese A., Egwuagu C.E., Gery I. Thymic expression of peripheral tissue antigens in humans: a remarkable variability among individuals. Int. Immunol. 2005, 17:1131-1140.
171. Tan C., Aziz M.K., Lovaas J.D., Vistica B.P., Shi G., Wawrousek E.F., Gery I. Antigen-specific Th9 cells exhibit uniqueness in their kinetics of cytokine production and short retention at the inflammatory site. J. Immunol. 2010, 185:6795-6801.
172. Tang J., Zhu W., Silver P.B., Su S.B., Chan C.C., Caspi R.R. Autoimmune uveitis elicited with antigen-pulsed dendritic cells has a distinct clinical signature and is driven by unique effector mechanisms: initial encounter with autoantigen defines disease phenotype. J. Immunol. 2007, 178:5578-5587.
173. Tsuchiya T., Fukuda S., Hamada H., Nakamura A., Kohama Y., Ishikawa H., Tsujikawa K., Yamamoto H. Role of gamma delta T cells in the inflammatory response of experimental colitis mice. J. Immunol. 2003, 171:5507-5513.
174. Uezu K., Kawakami K., Miyagi K., Kinjo Y., Kinjo T., Ishikawa H., Saito A. Accumulation of gamma delta T cells in the lungs and their regulatory roles in Th1 response and host defense against pulmonary infection with Cryptococcus neoformans. J. Immunol. 2004, 172:7629-7634.
175. Usui Y., Okunuki Y., Hattori T., Kezuka T., Keino H., Sugita S., Usui M., Goto H., Takeuchi M. Functional expression of B7H1 on retinal pigment epithelial cells. Exp. Eye Res. 2008, 86:52-59.
176. van Parijs L., Perez V.L., Abbas A.K. Mechanisms of peripheral T cell tolerance. Novartis Found Symp. 1998, 215:5-14. discussion 14-20, 33-40.
177. Vogt A. Fruhzeitiges ergrauen der Zilien und Bemerkungen uber den sogenannten plotzlichen Eintritt dieser Veranderung. K. Monatsbl. Augenhk. 1906, 44:228-242.
178. Wacker W.B., Lipton M.M. Experimental allergic uveitis homologous retina as uveitogenic antigen. Nature 1965, 206:253-254.
179. Wacker W.B., Donoso L.A., Kalsow C.M., Yankeelov J.A., Organisciak D.T. Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina. J. Immunol. 1977, 119:1949-1958.
180. Wenkel H., Streilein J.W. Analysis of immune deviation elicited by antigens injected into the subretinal space. Invest. Ophthalmol. Vis. Sci. 1998, 39:1823-1834.
181. Whitcup S.M., DeBarge L.R., Caspi R.R., Harning R., Nussenblatt R.B., Chan C.C. Monoclonal antibodies against ICAM-1 (CD54) and LFA-1 (CD11a/CD18) inhibit experimental autoimmune uveitis. Clin. Immunol. Immunopathol. 1993, 67:143-150.
182. Wilbanks G.A., Streilein J.W. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-suppressor cell populations. Immunology 1990, 71:383-389.
183. Wilbanks G.A., Streilein J.W. Studies on the induction of anterior chamber associated immune deviation (ACAID). I. Evidence that an antigen-specific, ACAID-inducing, cell-associated signal exists in the peripheral blood. J. Immunol. 1991, 146:2610-2617.
184. Wilbanks G.A., Mammolenti M.M., Streilein J.W. Studies on the induction of anterior chamber associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood borne signals that induce ACAID. J. Immunol. 1991, 146:3018-3024.
185. Wilbanks G., Streilein J.W. Macrophages capable of inducing anterior chamber associated immune deviation demonstrate spleen-seeking migratory properties. Reg. Immunol. 1992, 4:130-137.
186. Wildner G., Diedrichs-Möhring M. Autoimmune uveitis induced by molecular mimicry of peptides from rotavirus, bovine casein and retinal S-antigen. Eur. J. Immunol. 2003, 33:2577-2587.
187. Wildner G., Diedrichs-Möhring M. Autoimmune uveitis and antigenic mimicry of environmental antigens. Autoimmun. Rev. 2004, 3:383-387.
188. Wildner G., Diedrichs-Moehring M. Multiple autoantigen mimotopes of infectious agents induce autoimmune arthritis and uveitis in Lewis rats. Clin. Diag. Lab. Immunol. 2005, 12:677-679.
189. Wosik K., Biernacki K., Khouzam M.P., Prat A. Death receptor expression and function at the human blood brain barrier. J. Neurol. Sci. 2007, 259:53-60.
190. Xu H., Dawson R., Forrester J.V., Liversidge J. Identification of novel dendritic cell populations in normal mouse retina. Invest. Ophthalmol. Vis. Sci. 2007, 48:1701-1710.
191. Xu H., Manivannan A., Liversidge J., Sharp P.F., Forrester J.V., Crane I.J. Involvement of CD44 in leukocyte trafficking at the blood-retinal barrier. J. Leukoc. Biol. 2002, 72:1133-1141.
192. Yamada Y., Sugita S., Horie S., Yamagami S., Mochizuki M. Mechanisms of immune suppression for CD8+ T cells by human corneal endothelial cells via membrane-bound TGF. Invest. Ophthalmol. Vis. Sci. 2010, 51:2548-2557.
193. Yamagami S., Kawashima H., Tsuru T., Yamagami H., Yagita H., Okumura K., Gregerson D.S. Role of Fas-Fas ligand interactions in the immunorejection of allogenic mouse corneal transplants. Transplantation 1997, 64:1107-1111.
194. Yamaguchi K., Seiki M., Yoshida M., Nishimura H., Kawano F., Takatsuki K. The detection of human T-cell leukemia virus provirus DNA and its application for classification and diagnosis of T-cell malignancy. Blood 1984, 63:1235-1240.
195. Yamaguchi K., Mochizuki M., Watanabe T., Yoshimura K., Shirao M., Araki S., Miyata N., Mori S., Kiyokawa T., Takatsuki K. Human T lymphotropic virus type 1 uveitis after Graves' disease. Br. J. Ophthalmol. 1994, 78:163-166.
196. Yamaki K., Kondo I., Nakamura H., Miyano M., Konno S., Sakuragi S. Ocular and extraocular inflammation induced by immunization of tyrosinase related protein 1 and 2 in Lewis rats. Exp. Eye Res. 2000, 71:361-369.
197. Yamaki K., Gocho K., Hayakawa K., Kondo I., Sakuragi S. Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease. J. Immunol. 2000, 165:7323-7329.
198. Yamamoto K., Ishida T., Nakano K., Yamagishi M., Yamochi T., Tanaka Y., Furukawa Y., Nakamura Y., Watanabe T. SMYD3 interacts with HTLV-1 Tax and regulates subcellular localization of Tax. Cancer Sci. 2011, 102:260-266.
199. Yamano Y., Takenouchi N., Li H.C., Tomaru U., Yao K., Grant C.W., Maric D.A., Jacobson S. Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease. J. Clin. Invest. 2005, 115:1361-1368.
200. Yamazaki T., Akiba H., Miyazaki Y., et al. Expression of programmed death 1 ligands by murine T cells and APC. Immunology 2002, 169:5538-5545.
201. Yoshida M., Miyashi I., Hinuma Y. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its implication in the disease. Proc. Natl. Acad. Sci. U. S. A. 1982, 79:2031-2035.
202. Yoshida M., Seiki M., Yamaguchi K., Takatsuki K. Monoclonal integration of human T-cell leukemia provirus in all primary tumors of adult T-cell leukemia suggests causative role of human T-cell leukemia virus in the disease. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:2534-2537.
203. Yoshida M., Takeuchi M., Streilein J.W. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact. Invest. Ophthalmol. Vis. Sci. 2000, 41:811-821.
204. Yoshimura K., Mochizuki M., Araki S., Miyata N., Yamaguchi K., Tajima K., Watanabe T. Clinical and immunological features of human T-cell lymphotropic virus type I uveitis. Am. J. Ophthalmol. 1993, 116:156-163.
205. Yasunaga J., Sakai T., Nosaka K., Ki Etoh, Tamiya S., Koga S., Mita S., Uchino M., Mitsuya H., Matsuoka M. Impaired production of naive T lymphocytes in human T-cell leukemia virus type I-infected individuals: its implications in the immunodeficient state. Blood 2001, 97:3177-3183.
206. Yasunaga J., Matsuoka M. Molecular mechanisms of HTLV-1 infection and & pathogenesis. Int. J. Hematol. 2011, 94:435-442.
207. Zamiri P., Masli S., Streilein J.W., Taylor A.W. Pigment epithelial growth factor suppresses inflammation by modulating macrophage activation. Invest. Ophthalmol. Vis. Sci. 2006, 47:3912-3918.
208. Zhang M., Vacchio M.S., Vistica B.P., Lesage S., Egwuagu C.E., Yu C.R., Gelderman M.P., Kennedy M.C., Wawrousek E.F., Gery I. T cell tolerance to a neo-self antigen expressed by thymic epithelial cells: the soluble form is more effective than the membrane-bound form. J. Immunol. 2003, 170:3954-3962.
209. Zhou R., Horai R., Silver P.B., Mattapallil M.J., Zárate-Bladés C.R., Chong W.P., Chen J., Rigden R.C., Villasmil R., Caspi R.R. The living eye " disarms" uncommitted autoreactive T cells by converting them to Foxp3(+) regulatory cells following local antigen recognition. J. Immunol. 2012, 188:1742-1750.